Rare diseases
Investigational molecules
Locations
A study to evaluate the effectiveness and safety of Usnoflast in adults with Amyotrophic Lateral Sclerosis (ALS)
BelgiumStudy of Sotorasib, Panitumumab and a drug combination for patients with metastatic colorectal cancer with KRAS p.G12C mutation.
AustriaStudy to evaluate the long-term safety and effectiveness of lunsekimig in adults with moderate to severe asthma
BelgiumStudy of BNT327 and a drug combination for patients with untreated metastatic or locally recurrent triple-negative breast cancer
BelgiumA study to evaluate the effectiveness and safety of ritlecitinib tosilate and loratadine in adults with chronic spontaneous urticaria (hives)
BulgariaA study to evaluate the effectiveness and safety of duvakitug in patients with moderate to severe Crohn's disease
AustriaA study to evaluate the efficacy and safety of duvakitug in patients with moderate to severe Crohn's disease
AustriaPhase III Randomized Study of Rilvegostomig vs. Pembrolizumab with Platinum-based Chemotherapy in PD-L1 Expressing Metastatic Squamous NSCLC
AustriaA Study Comparing Empasiprubart Versus Intravenous Immunoglobulin in Adults With Chronic Inflammatory Demyelinating Polyneuropathy
AustriaA study to evaluate the safety of dazodalibep in patients with Sjögren's Syndrome over a long period of time
BelgiumStudy of BNT327 with etoposide and carboplatin compared to atezolizumab with etoposide and carboplatin for patients with untreated extensive-stage small-cell lung cancer
FranceA study testing GSK3862995B compared to placebo for safety and effectiveness in adults aged 18 to 85 years with bronchiectasis
DenmarkTell us about your condition – we search every trial in Europe and connect you with the right site.
